Variable | n = 74 | HbA1c < 7.0% n = 38 | HbA1c ≥ 7.0% n = 36 | p value |
---|---|---|---|---|
Age (years) | 65.6 ± 6.8 | 66.0 ± 6.7 | 65.2 ± 7.1 | 0.62 |
Female gender, n (%) | 26 (35.1) | 10 (26.3) | 16 (44.4) | 0.10 |
Hypertension, n (%) | 72 (97.3) | 37 (97.4) | 35 (97.2) | 0.97 |
Hyperlipidemia, n (%) | 50 (67.6) | 24 (63.2) | 26 (72.2) | 0.41 |
Metabolic syndrome, n (%) | 74 (100.0) | 38 (100.0) | 36 (100.0) | 1.00 |
Obesity, n (%) | 49 (66.2) | 26 (68.4) | 23 (63.9) | 0.68 |
Waist circumference (cm) | 106.5 ± 9.4 | 106.7 ± 9.1 | 106.2 ± 9.8 | 0.83 |
Body mass index, kg/m2 | 31.2 ± 3.6 | 31.1 ± 3.0 | 31.3 ± 4.1 | 0.81 |
Body fat (%) | 34.1 ± 8.6 | 32.9 ± 7.4 | 35.4 ± 9.6 | 0.23 |
Visceral fat (%) | 16.0 ± 4.7 | 16.4 ± 5.0 | 15.5 ± 4.2 | 0.53 |
Total body water (%) | 47.6 (44.2; 49.3) | 48.6 (44.2; 49.3) | 47.2 (44.0; 49.1) | 0.45 |
Muscle mass (kg) | 55.2 ± 10.4 | 56.1 ± 8.6 | 54.0 ± 12.7 | 0.51 |
Medical history | ||||
 T2DM duration (years) | 10 (6; 15) | 9 (4; 10) | 10 (7; 20) | 0.02 |
 CAD, n (%) | 74 (100.0) | 38 (100.0) | 36 (100.0) | 1.00 |
 PAD, n (%) | 26 (35.1) | 10 (26.3) | 16 (44.4) | 0.10 |
 Previous MI, n (%) | 28 (37.8) | 17 (44.7) | 11 (30.6) | 0.21 |
 Previous PCI, n (%) | 47 (65.5) | 25 (65.8) | 22 (61.1) | 0.68 |
Treatment | ||||
 ASA, n (%) | 74 (100.0) | 38 (100.0) | 36 (100.0) | 1.00 |
 Clopidogrel, n (%) | 33 (44.5) | 16 (42.1) | 17 (47.2) | 0.66 |
 Beta blocker, n (%) | 61 (82.4) | 32 (84.2) | 29 (80.6) | 0.68 |
 ACE inhibitor or ARB, n (%) | 67 (90.5) | 33 (86.8) | 34 (94.4) | 0.26 |
 Nitrate long acting, n (%) | 11 (14.9) | 5 (13.2) | 6 (16.7) | 0.67 |
 Calcium antagonist, n (%) | 32 (43.2) | 15 (39.5) | 17 (47.2) | 0.50 |
 Statin, n (%) | 68 (91.9) | 34 (89.5) | 34 (94.4) | 0.43 |
 Fibrate, n (%) | 1 (1.4) | 0 | 1 (2.8) | 0.30 |
 Diuretic, n (%) | 22 (29.7) | 9 (23.7) | 13 (36.1) | 0.24 |
 MRA, n (%) | 9 (12.2) | 4 (10.5) | 5 (13.9) | 0.66 |
 Metformin, n (%) | 49 (66.2) | 27 (71.1) | 22 (61.1) | 0.37 |
 Sulfonylurea, n (%) | 31 (41.9) | 19 (50.0) | 12 (33.3) | 0.15 |
 Acarbose, n (%) | 1 (1.4) | 0 | 1 (2.8) | 0.30 |
 DPP-IV, n (%) | 3 (4.1) | 2 (5.3) | 1 (2.8) | 0.59 |
 Insulin, n (%) | 32 (43.2) | 9 (23.7) | 23 (63.9) | 0.0005 |
 PPI, n (%) | 22 (29.7) | 9 (23.7) | 13 (36.1) | 0.24 |